Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0EZZAW
ADC Name
PEN-221
Synonyms
PEN 221; PEN221
   Click to Show/Hide
Organization
Tarveda Therapeutics, Inc.
Drug Status
Phase 1/2
Indication
In total 5 Indication(s)
Colorectal cancer
Phase 2
Clinical Trial
Gastric cancer
Phase 2
Clinical Trial
Lung cancer
Phase 2
Clinical Trial
Pancreatic cancer
Phase 2
Clinical Trial
Thymus cancer
Phase 2
Clinical Trial
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
Undisclosed
Antigen Name
Somatostatin receptor type 2 (SSTR2)
  Antigen Info 
Payload Name
Mertansine DM1
  Payload Info 
Therapeutic Target
Microtubule (MT)
  Target Info 
Conjugate Type
Undisclosed